Dietary Supplements: Navigating the Regulatory Maze
Diagnosing Health Care Podcast
Release Date: 11/02/2023
Health Policy Update: Impact of the 2024 U.S. Elections
Diagnosing Health Care Podcast
The recent 2024 elections resulted in a new Trump administration and a Republican-controlled House and Senate. From policymakers to stakeholders across the industry, everyone is wondering what health policy will look like in 2025 and beyond. On this episode, Epstein Becker Green attorneys , , , and discuss the results of the 2024 elections and their impact on the health policy space. What will a second Trump administration look like? How might the election results affect the health care policies addressed during Congress’s 2024 lame-duck session? Visit our site for related resources and...
info_outline
Advancements of Artificial Intelligence in Health Care – One Year After White House Executive Order
Diagnosing Health Care Podcast
One year ago, on October 30, 2023, President Joe Biden signed an executive order laying the groundwork both for how federal agencies should responsibly incorporate artificial intelligence (AI) within their workflows and how each agency should regulate the use of AI in the industries it oversees. What has happened in the past year, and how might things change in the next? On this episode, Epstein Becker Green attorneys , , and reflect on what is new in health care AI as a result of the 2023 executive order and discuss what industry stakeholders should be doing to comply and prepare for...
info_outline
Workplace Violence in Health Care: Dissecting the Legal Landscape and Implications for Employers
Diagnosing Health Care Podcast
Workplace violence in health care settings is on the rise, capturing the attention of both state and federal lawmakers. As awareness grows, so too does legal scrutiny and the push for new regulations and enforcement. In these seemingly critical times, what should health care employers be thinking about and incorporating into their comprehensive strategies to prevent and address workplace violence? On this episode, Epstein Becker Green attorneys , , and dissect the legal landscape surrounding health care workplace violence, examining the steps being taken at various levels of...
info_outline
Navigating the Labyrinth of Private Equity Investments in Health Care
Diagnosing Health Care Podcast
The game has changed—are you positioned to adapt? Over the past 12 months, the federal government has been heavily regulating private investment in health care entities. Simultaneously, multiple states have enacted or introduced new laws restricting or requiring approval of such investments. The question arises: What do you do if you already have investments in these health care entities? On this episode, , Strategic Counsel at Epstein Becker Green (EBG), joins EBG attorneys , , and to discuss how health care entities, investors, and board members should be responding to an...
info_outline
The DEA Is Knocking at Your Door . . . Are You Prepared?
Diagnosing Health Care Podcast
Knock, knock! If the Drug Enforcement Administration (DEA) is already at your door, it may be too late. Enforcement is on the rise, and the microscope is fixed on controlled substances. What can industry stakeholders do to prevent penalties and protect themselves from DEA scrutiny? On this episode, Epstein Becker Green attorneys , , and discuss recent and pending updates to DEA rules and guidance, outline steps stakeholders can take to prepare for an inspection, and share tips on what to do when the DEA arrives. Visit our site for more information and related resources: Subscribe for...
info_outline
The Future of Laboratory Testing Just Got a Little Clearer: FDA's Final Rule on LDTs
Diagnosing Health Care Podcast
Laboratories in the United States are facing a major regulatory landscape shift. The U.S. Food and Drug Administration (FDA) has finalized a new rule ending its historical blanket enforcement discretion over laboratory developed tests (LDTs). What does this mean for labs going forward? On this episode, Epstein Becker Green attorneys , , and lay out the new landscape, analyze existing and potential challenges, and identify key developments to watch for as this new regulatory era unfolds. Visit our site for more information and related resources: Subscribe for email...
info_outline
Down Goes Chevron: A 40-Year Precedent Overturned by the Supreme Court
Diagnosing Health Care Podcast
In a recent landmark decision, the U.S. Supreme Court overruled the Chevron doctrine in the case of Loper Bright Enterprises v. Raimondo. This ruling has significant implications for employers and other entities in the health care and life sciences industries, as it changes the way courts are likely to interpret and apply regulations issued by federal agencies. On this episode, Epstein Becker Green attorneys , , , and analyze the fallout of this monumental decision, discuss what it means for entities seeking to challenge ambiguous statutes and regulations, and assess how to proceed...
info_outline
If Cannabis Is Reclassified, What Will Happen to the Marketplace?
Diagnosing Health Care Podcast
Will the reclassification of marijuana from a Schedule I to a Schedule III drug disrupt the cannabis marketplace? What consequences must industry stakeholders consider if the Drug Enforcement Administration's proposal becomes a reality? On this episode, special guests , a New Jersey-licensed pharmacist, and , an accountant with expertise in representing cannabis operators across the United States, join Epstein Becker Green attorney to discuss the regulatory domino effect and tax implications related to this major potential change to the cannabis industry. Visit our site for more information...
info_outline
Unveiling Gender-Affirming Care: Why It Matters and What's at Stake
Diagnosing Health Care Podcast
Gender-affirming care has become the latest flashpoint in state legislatures and state and federal courts across the nation. States are divided, with some passing laws that seek to restrict access to gender-affirming care and others aiming to protect access. What is gender-affirming care? What risks does it pose to providers and patients? On this episode, Epstein Becker Green attorneys , , and dissect gender-affirming care: what it is, what it isn't, and what is at stake for everyone involved. Visit our site for more information and related resources: Subscribe for email...
info_outline
Key Changes in Finalized Antitrust Merger Guidelines
Diagnosing Health Care Podcast
After nearly two years of combined efforts from the Federal Trade Commission and the Antitrust Division of the Department of Justice, the agencies jointly issued much-anticipated merger guidelines identifying the procedures and enforcement practices they will apply for evaluating potential mergers. What might these changes mean for hospitals, health systems, and other stakeholders in the health care industry? On this episode, we discuss some of the key changes in the finalized antitrust merger guidelines and what these guidelines mean for the agencies' approach to enforcement. Visit our site...
info_outlineThe U.S. Food and Drug Administration’s (FDA’s) broad definition of “misbranding” has created some industry confusion, while the Federal Trade Commission’s (FTC’s) updates to its health products compliance guidance have done the same. In light of these recent actions, what challenges are dietary supplement manufacturers now facing? On this episode, Epstein Becker Green attorneys Jack Wenik, Teddy McCormick, Zach Taylor, and Tracey Gonzalez discuss recent updates to the FDA and FTC guidelines as they apply to dietary supplement manufacturers, as well as new developments with respect to misbranding.
Visit our site for more information and related resources: https://www.ebglaw.com/dhc71
Subscribe for email notifications: https://www.ebglaw.com/subscribe.
Visit: http://diagnosinghealthcare.com.
This podcast is presented by Epstein Becker & Green, P.C. All rights are reserved. This audio recording includes information about legal issues and legal developments. Such materials are for informational purposes only and may not reflect the most current legal developments. These informational materials are not intended, and should not be taken, as legal advice on any particular set of facts or circumstances, and these materials are not a substitute for the advice of competent counsel. The content reflects the personal views and opinions of the participants. No attorney-client relationship has been created by this audio recording. This audio recording may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules. The determination of the need for legal services and the choice of a lawyer are extremely important decisions and should not be based solely upon advertisements or self-proclaimed expertise. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.